Nova Southeastern University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 4
Founded: Fort Lauderdale FL United States (1964)

Organization Overview

First Clinical Trial
2011
NCT01366859
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

College of Pharmacy, Nova Southeastern University | Larkin Community Hospital/Nova Southeastern University | Nova Southeastern Univeristy | Nova Southeastern University

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Autism Spectrum Disorder (Phase 2)

Autistic Disorder (Phase 2)

Headache (Phase 4)

Iritis (Phase 2)

Occupational Diseases (Phase 1)

Parkinson Disease (Phase 2)

Persian Gulf Syndrome (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 9
  • # of Trial APIs: 11